Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

FDA approves Novartis' Xolair for Rare Skin Disease

March 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

Texas A&M Center Adds Mobile Cleanrooms

March 13, 2014

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies

March 12, 2014

$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.

Almac Expands Asia Pacific Operations

March 12, 2014

Almac expands technical, project, and operational resources in Asia.

CPhI Report Shows R&D Market Diversifying

March 7, 2014

CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.

Cobra Biologics and BioCancell Collaborate on Cancer Therapy Drug

March 7, 2014

Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.

Johnson Controls Launches Integrated Laboratory Services

March 7, 2014

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

Waters Marks Ten Years of ACQUITY UPLC With the Introduction of New Products

March 4, 2014

Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.

FDA Approves Orphan Drug Myalept

February 26, 2014

FDA approves the orphan drug Myalept for the treatment of leptin deficiency.

ADVERTISEMENT

ADVERTISEMENT

Click here